The role of duloxetine in the treatment of anxiety disorders

QR Code

The role of duloxetine in the treatment of anxiety disorders

Domenico De Berardis1,2,3, Nicola Serroni2, Alessandro Carano1,4, Marco Scali1,4, Alessandro Valchera5, Daniela Campanella1,2, Alessandro D&rsquo;Albenzio1, Berardo Di Giuseppe2, Francesco Saverio Moschetta2, Rosa Maria Salerno1, Filippo Maria Ferro11Department of Oncology and Neurosciences,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Domenico De Berardis, Nicola Serroni, Alessandro Carano, Marco Scali, Alessandro Valchera, et al
Format:	article
Language:	EN
Published:	Dove Medical Press 2008
Subjects:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Online Access:	https://doaj.org/article/a5df458efc8343dda82baca21994ae6f
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Duloxetine in the treatment of generalized anxiety disorder
by: Trevor R Norman, et al.
Published: (2009)

Duloxetine for the treatment of generalized anxiety disorder: a review
by: Ahsan Y Khan, et al.
Published: (2008)

Duloxetine in panic disorder with somatic gastric pain
by: Preve M, et al.
Published: (2013)

Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
by: Michele Fornaro, et al.
Published: (2011)

Evidence to practice: treatment of anxiety in individuals with autism spectrum disorders
by: Russell Lang, et al.
Published: (2011)

New treatment options for fibromyalgia: critical appraisal of duloxetine
by: Nurcan &Uuml;&ccedil;eyler, et al.
Published: (2008)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
by: Bernhard T Baune
Published: (2008)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
by: Maneeton B, et al.
Published: (2018)

Pregabalin for the treatment of generalized anxiety disorder: an update
by: Baldwin DS, et al.
Published: (2013)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
by: Harada E, et al.
Published: (2015)

Role of paliperidone extended-release in treatment of schizoaffective disorder
by: Carla M Canuso, et al.
Published: (2010)

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
by: Prasko J, et al.
Published: (2016)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
by: Levitan MN, et al.
Published: (2015)

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review
by: Fornaro M, et al.
Published: (2016)

Differential attentional bias in generalized anxiety disorder and panic disorder
by: Chen J, et al.
Published: (2013)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
by: Haider M, et al.
Published: (2017)

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
by: Nagao K, et al.
Published: (2013)

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
by: Atake K, et al.
Published: (2015)

Epilepsy and suicide: pathogenesis, risk factors, and prevention
by: Alberto Verrotti, et al.
Published: (2008)

The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
by: Peedicayil J
Published: (2020)

Anxiety disorders and GABA neurotransmission: a disturbance of modulation
by: Nuss P
Published: (2015)

A review of neuroimaging studies of anxiety disorders in China
by: Chen J, et al.
Published: (2011)

Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment
by: G&eacute;rard A, et al.
Published: (2012)

Social anxiety disorder: A review of environmental risk factors
by: Christina A Brook, et al.
Published: (2008)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
by: Huang J, et al.
Published: (2018)

Imitation and communication skills development in children with pervasive developmental disorders
by: Andrea De Giacomo, et al.
Published: (2009)

Transcranial magnetic stimulation for the treatment of anxiety disorder
by: Rodrigues PA, et al.
Published: (2019)

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
by: Zou C, et al.
Published: (2013)

Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities
by: Ociskova M, et al.
Published: (2015)

Movement Disorders Associated with COVID-19
by: Mehri Salari, et al.
Published: (2021)

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
by: Kuga A, et al.
Published: (2017)

SAFA: A new measure to evaluate psychiatric symptoms detected in a sample of children and adolescents affected by eating disorders. Correlations with risk factors
by: Emilo Franzoni, et al.
Published: (2009)

Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
by: Tian-Xiang Zhang, et al.
Published: (2021)

Examining the effect of a wearable, anxiety detection technology on improving the awareness of anxiety signs in autism spectrum disorder: a pilot randomized controlled trial
by: Jenny Nguyen, et al.
Published: (2021)

Cognitive impairment in generalized anxiety disorder revealed by event-related potential N270
by: Yang Y, et al.
Published: (2015)

The role of paliperidone extended release for the treatment of bipolar disorder
by: Marino J, et al.
Published: (2012)

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study
by: Fontani V, et al.
Published: (2011)

Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
by: Ariadna Laguna, et al.
Published: (2021)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
by: Jean-Michel Azorin, et al.
Published: (2010)